OptimizeRx Corp SEC filings OPRX

OptimizeRx Corp has 1,000 filings in SEC EDGAR's recent list, going back to Oct 12, 2010. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Jun 1, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 9, 2026
DEF 14A Proxy statement Apr 30, 2025 Jun 11, 2025
DEFA14A Additional proxy material Mar 11, 2025 —
DEF 14A Proxy statement Apr 29, 2024 Jun 5, 2024
DEF 14A Proxy statement Apr 25, 2023 Jun 7, 2023
DEF 14A Proxy statement Apr 25, 2022 Jun 9, 2022
DEF 14A Proxy statement Jul 8, 2021 Aug 19, 2021
DEF 14A Proxy statement Oct 1, 2020 Nov 19, 2020
DEF 14A Proxy statement Sep 24, 2019 Nov 4, 2019
DEF 14C Information statement Jun 17, 2013 Jun 17, 2013

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Business Services, NEC (SIC 7389)
Listed as
OPRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Waltham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1448431

Other Services-Business Services, NEC companies

All 136 Services-Business Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.